The proteasome: A molecular target for cancer therapy

被引：6
|
作者：
Hallahan, DE [1 ]
Teng, M [1 ]
机构：
[1] Vanderbilt Univ, Dept Radiat Oncol, Vanderbilt Clin B902, Nashville, TN 37232 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2000年 / 47卷 / 04期
关键词：
D O I：
10.1016/S0360-3016(00)00517-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：859 / 860
页数：2
相关论文
共 50 条
  • [31] Pancreatic cancer: From molecular signature to target therapy
    Longo, R.
    Cacciamani, F.
    Naso, G.
    Gasparini, G.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 68 (03) : 197 - 211
  • [32] Thioredoxin reductase as a novel molecular target for cancer therapy
    Nguyen, Phuongmai
    Awwad, Rania T.
    Smart, Dee Dee K.
    Spitz, Douglas R.
    Gius, David
    CANCER LETTERS, 2006, 236 (02) : 164 - 174
  • [33] Recent progress of molecular target therapy for breast cancer
    Saji, Shigehira
    ANNALS OF ONCOLOGY, 2017, 28 : 64 - 64
  • [34] Molecular Diagnosis for Personalized Target Therapy in Gastric Cancer
    Cho, Jae Yong
    JOURNAL OF GASTRIC CANCER, 2013, 13 (03) : 129 - 135
  • [35] Molecular target-based therapy of pancreatic cancer
    Lebedeva, IV
    Sarkar, D
    Su, ZZ
    Gopalkrishnan, RV
    Athar, M
    Randolph, A
    Valerie, K
    Dent, P
    Fisher, PB
    CANCER RESEARCH, 2006, 66 (04) : 2403 - 2413
  • [36] Molecular Pathways: The Necrosome-A Target for Cancer Therapy
    Seifert, Lena
    Miller, George
    CLINICAL CANCER RESEARCH, 2017, 23 (05) : 1132 - 1136
  • [37] Efp as a new molecular target for breast cancer therapy
    Horie, K
    Urano, T
    Inoue, S
    ANTI-CANCER DRUGS, 2003, 14 (01) : 1 - 2
  • [38] Mesothelin, a Novel Molecular Target for Gene Therapy of Cancer
    Bodempudi, Vidya
    Yamoutpour, Farnaz
    Meyer, Anna
    Esfandyari, Tuba
    Farassati, Faris
    MOLECULAR THERAPY, 2009, 17 : S115 - S115
  • [39] Special Issue: The Proteasome: An important player in tumor progression and a novel target for cancer therapy Preface
    Dou, Q. Ping
    CANCER AND METASTASIS REVIEWS, 2017, 36 (04) : 559 - 560
  • [40] Protein degradation as a target for anticancer therapy: molecular mechanisms of efficacy and acquired resistance to proteasome and aminopeptidase inhibitors
    Peters, G. J.
    Ossenkoppele, G. J.
    Cloos, J.
    Jansen, G.
    AMINO ACIDS, 2016, 48 (02) : 616 - 616
12345